Article
Early Canadian Real-World Experience with Brolucizumab in Anti-Vascular Endothelial Growth…
Clinical Ophthalmology · 2022 · Giunta M, Gauvin Meunier LP, Nixon D, Steeves J, Noble J
Key facts
| Title | Early Canadian Real-World Experience with Brolucizumab in Anti-Vascular Endothelial Growth Factor-Experienced Patients with Neovascular Age-Related Macular Degeneration: A Retrospective Chart Review |
|---|---|
| First author | Giunta M, Gauvin Meunier LP, Nixon D, Steeves J, Noble J |
| Journal | Clinical Ophthalmology |
| Published | Aug 30, 2022 |
| DOI | 10.2147/OPTH.S376199 |
| Devices mentioned | K780428, K791373, K801244, K820613, K820614, K820942 |
| Product codes mentioned | CFE, JHI, JLW |
At a glance
- 1–9 FDA submissions mentioned
- 1–9 Product codes mentioned
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About Literature
Peer-reviewed and preprint literature indexed by Orca1 and linked to the FDA submissions and product codes each article mentions. Only bibliographic details are shown here.
Source: Publisher and PubMed metadata; device mentions identified by Orca1